Simplex Trading, LLC Clene Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$0.31 - $0.44 $589 - $836	1,900 Added 70.95%	4,578 $1,000
Q1 2024 Apr 25, 2024	SELL	$0.28 - $0.53 $72 - $136	-258 Reduced 8.79%	2,678 $1,000
Q4 2023 Feb 02, 2024	SELL	$0.26 - $0.55 $12,847 - $27,177	-49,414 Reduced 94.39%	2,936 $0
Q3 2023 Nov 01, 2023	BUY	$0.46 - $0.87 $1,439 - $2,722	3,129 Added 6.36%	52,350 $26,000
Q2 2023 Aug 04, 2023	BUY	$0.78 - $1.22 $4,093 - $6,402	5,248 Added 11.93%	49,221 $43,000
Q1 2023 Apr 27, 2023	SELL	$0.95 - $1.62 $45,901 - $78,273	-48,317 Reduced 52.35%	43,973 $49,000
Q4 2022 Feb 02, 2023	SELL	$0.92 - $40.2 $36,915 - $1.61 Million	-40,125 Reduced 30.3%	92,290 $92,000
Q3 2022 Nov 04, 2022	BUY	$0.33 - $73.0 $43,183 - $9.55 Million	130,860 Added 8415.43%	132,415 $370,000
Q2 2022 Aug 03, 2022	SELL	$2.1 - $4.12 $16,098 - $31,583	-7,666 Reduced 83.14%	1,555 $3,000
Q1 2022 May 02, 2022	BUY	$2.42 - $4.42 $20,107 - $36,725	8,309 Added 911.07%	9,221 $36,000
Q4 2021 Feb 23, 2022	BUY	$3.95 - $7.53 $3,602 - $6,867	912 New	912 $3,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $273M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.